HOW CONTROVERSIAL ARE SURROGATE END-POINTS

被引：4
|
作者：
MAMELOK, R
机构：
来源：
BIO-TECHNOLOGY | 1994年 / 12卷 / 02期
关键词：
D O I：
10.1038/nbt0294-134
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：134 / 135
页数：2
相关论文
共 50 条
  • [21] Can good surrogate end-points predict the prognosis of hypertensive patients?
    Mancia, G
    Lanfranchi, A
    Turri, C
    Grassi, G
    JOURNAL OF HYPERTENSION, 1998, 16 : S3 - S7
  • [22] A 2-STAGE PROCEDURE FOR SURVIVAL STUDIES WITH SURROGATE END-POINTS
    FLANDRE, P
    OQUIGLEY, J
    BIOMETRICS, 1995, 51 (03) : 969 - 976
  • [23] ROLE OF SURROGATE END-POINTS IN THE EVALUATION OF DRUGS FOR HEART-FAILURE
    LIPICKY, RJ
    PACKER, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) : A179 - A184
  • [24] INCOMPLETE MULTIRESPONSE DESIGNS AND SURROGATE END-POINTS IN CLINICAL-TRIALS
    SEN, PK
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 1994, 42 (1-2) : 161 - 186
  • [25] Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)
    Vestbo, J.
    Anderson, W.
    Coxson, H. O.
    Crim, C.
    Dawber, F.
    Edwards, L.
    Hagan, G.
    Knobil, K.
    Lomas, D. A.
    MacNee, W.
    Silverman, E. K.
    Tal-Singer, R.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (04) : 869 - 873
  • [26] Surrogate end-points in clinical practice: are we providing worse care?
    Martin, J. H.
    Fay, M. F.
    INTERNAL MEDICINE JOURNAL, 2010, 40 (06) : 395 - 398
  • [27] Clinically meaningful end-points: Long term survival end-points versus early time to event based end-points
    Pignatti, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S18 - S18
  • [28] MEDICAL END-POINTS
    MCGREGOR, DD
    BENJAMIN, RB
    BERENDES, HW
    BERNSTEIN, GS
    COULSON, AH
    CROZIER, R
    EMSLANDER, RF
    QUIROGA, J
    SCHMIDT, S
    SCHUMAN, LM
    SULLIVAN, T
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (08) : 753 - 768
  • [29] POLARISATION END-POINTS
    EVANS, DP
    ANALYST, 1947, 72 (852) : 99 - 101
  • [30] Biological surrogate end-points in cancer trials: Potential uses, benefits and pitfalls
    Cooper, R
    Kaanders, JHAM
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (09) : 1261 - 1266
12345